102
Participants
Start Date
September 30, 2013
Primary Completion Date
June 19, 2019
Study Completion Date
June 19, 2019
aMIL
On day 0, patients will receive auto transplant followed by Tadalafil and aMIL. At day 60, patients will receive Lenalidomide.
No aMIL
On day 0, patients will receive auto transplant followed by Tadalafil. At day 60, patients will receive Lenalidomide.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
The Leukemia and Lymphoma Society
OTHER
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER